awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48267202-8AD05530-FD4F-4044-BB69-AA62A2FF4107
Q48267202-8AD05530-FD4F-4044-BB69-AA62A2FF4107
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48267202-8AD05530-FD4F-4044-BB69-AA62A2FF4107
Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes.
P2860
Q48267202-8AD05530-FD4F-4044-BB69-AA62A2FF4107
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48267202-8AD05530-FD4F-4044-BB69-AA62A2FF4107
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb3468056a87806dc27789b2289e455e9e011b05
P2860
Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes.